SLF
CELG

Sun Life Financial’s Celgene Corp CELG Stock Holding History

Sun Life Financial’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-578
Closed -$57K – 619
2019
Q3 		$57K Buy
578
+8
+1% +$760 0.01% 280
2019
Q2 		$53K Sell
570
-623
-52% -$59.2K 0.01% 287
2019
Q1 		$113K Sell
1,193
-747
-39% -$65.3K 0.03% 258
2018
Q4 		$124K Buy
1,940
+12
+0.6% +$886 0.03% 260
2018
Q3 		$173K Buy
1,928
+10
+0.5% +$884 0.03% 257
2018
Q2 		$152K Buy
1,918
+1,613
+529% +$134K 0.02% 263
2018
Q1 		$3.42K Sell
305
-1,417
-82% -$136K 0.03% 169
2017
Q4 		$180K Sell
1,722
-4,031
-70% -$455K 0.02% 151
2017
Q3 		$839K Buy
5,753
+163
+3% +$22.2K 0.08% 90
2017
Q2 		$726K Buy
5,590
+5,289
+1,757% +$648K 0.08% 87
2017
Q1 		$2.42K Buy
301
+253
+527% +$30.3K 0.01% 114
2016
Q4 		$416 Buy
+48
New +$5.34K ﹤0.01% 137

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Sun Life Financial's CELG Position: Q4 2019 in Review

Sun Life Financial sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 578 shares — an estimated $57K sold.

Sun Life Financial first reported a position in CELG in Q4 2016 and held it in 12 quarters. The position peaked at $839K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Sun Life Financial reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Sun Life Financial sold 578 Celgene Corp shares in Q4 2019, an estimated $57K.
  • Sun Life Financial first reported a position in Celgene Corp in Q4 2016 and held it in 12 quarters.
  • Sun Life Financial's Celgene Corp position peaked at $839K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Sun Life Financial's 13F filing for Q4 2019, filed 10 Feb 2020.